Tag: pharmaceuticals
-

New Company IDs Drugs Targeting Cancer Cell Networks
A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors.
-

FDA Bucks White House, Issues Strict Vaccine Guidance
The U.S. Food and Drug Administration yesterday issued guidance for Covid-19 vaccine developers, requiring extended follow-up with clinical trial participants.
-

Microbiome Therapies Company Unveils, Raises $50M
A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer.
-

Engineered Heart Tissue Mechanisms Probed
A research institute is partnering with a company creating heart tissue patches from stem cells to better understand the details of how the patch works.
-

Heart Disease Biotech Acquired in $13.1B Deal
A company developing precision medicine drugs to treat inherited heart disorders was acquired by drug maker Bristol Myers Squibb, or BMS, for $13.1 billion.
-

BARDA Funding Vaccine Patch Clinical Trial
The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes.
-

Int’l Lab Network to Assess Covid-19 Vaccines
Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols.
-

Biotech, Analytics Companies Partner on Drug Discovery
A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases.
-

Group Advancing Electronic Spinal Cord Injury Therapies
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries.
-

Mixed Early Results in Covid-19 Antibody Cocktail Trial
The developer of a synthetic antibody cocktail to treat non-hospitalized Covid-19 patients released first results from a clinical trial with some encouraging findings.